Achieve Life Sciences Inc
Abierto
5.56 0.54
Resumen
Variación precio
24h
Mínimo
5.51
Máximo
5.73
Ingresos | 4.5M -10M |
|---|---|
BPA | -0.19 |
Empleados | 28 |
EBITDA | 4.3M -10M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 Meses | +139.13% upside |
Próximas Ganancias | 6 ago 2026 |
|---|
Capitalización Mercado | -1M 573M |
|---|---|
Apertura anterior | 5.02 |
Cierre anterior | 5.56 |
Achieve Life Sciences Inc Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Achieve Life Sciences Inc
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
